SANTA MONICA, Calif. , March 31, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals , Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical

Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

About Opiant Pharmaceuticals Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing pharmacological treatments for addictions. NIDA, a division of the NIH, describes these disorders as chronic relapsing brain diseases which burden society at … Opiant Pharmaceuticals revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that its … 2021-04-08 · Get the latest Opiant Pharmaceuticals, Inc. (OPNT) stock news and headlines to help you in your trading and investing decisions. SANTA MONICA, Calif.

Opiant pharmaceuticals news

For more information, visit Find the latest Opiant Pharmaceuticals, Inc. (OPNT) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-13 · OPNT Opiant Pharmaceuticals Inc Current Report Filing (8-k) On April 12, 2021, the Board of Directors (the “Board”) of Opiant Pharmaceuticals, Inc. (the “Company”) adopted stock ownership guidelines for the Company’s non-employee directors and executive officers to help ensure that they each maintain an equity stake in the Company and, by doing so, appropriately link their interests 2021-03-04 · Wall Street analysts have given Opiant Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Opiant Pharmaceuticals wasn't one of them. Keep up to date with the progress and innovation at Opiant by reading through our news publications from a variety of sources. 2021-04-08 · Opiant Pharmaceuticals News . Follow OPNT.

All·Sentiment·News·Trading Stats·Key Stockopedia rates Opiant Pharmaceuticals Inc as a Adventurous Style Latest News for OPNT Opiant Pharmaceuticals Inc Annual Shareholders Meeting.

Opiant Pharmaceuticals (OPNT) has been awarded the third and final tranche of$1.8M from the total grant of about $7.4M from the National Institute on Drug Abuse, part of the

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-03-22 NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call … 2021-04-05 2021-04-13 About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose. The National Institute on Drug Abuse, a component of the NIH, describes addictive disorders as chronic relapsing brain diseases which burden society at both the individual and community levels.

Opiant Pharmaceuticals news and OPNT price. Free real-time prices, trades, and chat.

NIDA, a division of the NIH, describes these disorders as chronic relapsing brain diseases which burden society at … Opiant Pharmaceuticals revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that its … 2021-04-08 · Get the latest Opiant Pharmaceuticals, Inc. (OPNT) stock news and headlines to help you in your trading and investing decisions. SANTA MONICA, Calif.

10.61 0.03 (0.28%) Upgrade to Real-Time Regular Market . Proxy Statement - Merger or Acquistion (preliminary) (prem14a) Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. We are headquartered in Santa Monica, with additional offices in London, UK. We were founded in 2009. In 2013, Opiant developed the first FDA-approved, user-friendly nasal naloxone spray. Opiant Pharmaceuticals (NASDAQ OPNT) News Headlines Today Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Get the latest Opiant Pharmaceuticals (OPNT) stock price quote with real-time news, financials, charts and other important investing information. 2021-03-22 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Autoimmun hypotyreose

2021-04-08 · Opiant Pharmaceuticals News . Follow OPNT.

Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is Opiant Pharmaceuticals posted sales of $4.28 million during the same quarter last year, which would indicate a positive year over year growth rate of 28%. The company is expected to announce its next quarterly earnings results on Tuesday, May 11th. About us Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Båtkörkortet förarintyg & kustskepparintyg

deklarera avdrag dubbelt boende
metoddiskussion c-uppsats
hammaren barnehage sola
sommarjobb platsbanken 2021
tyn lon volvo
upplysning engelska

2021-03-31

Get the latest Opiant Pharmaceuticals (OPNT) stock price quote with real-time news, financials, charts and other important investing information. Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 9 at 8:10 AM: Opiant Pharmaceuticals EPS beats by $0.19, beats on revenue seekingalpha.com - August 6 at 9:08 PM: Opiant Pharmaceuticals Announces Second Quarter 2020 Financial Results and Corporate Update 2021-04-05 A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.